Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DMRA/Capital expenditures

DAMORA THERAPEUTICS, INC. (DMRA) Capital expenditures 2022–2023

DAMORA THERAPEUTICS, INC. (DMRA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$196,000FY2023 · since FY2022: $223,000 → $196,000
2223
Fiscal yearValueYoY
FY2023$196,000-12.1%
FY2022$223,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More DMRA financial trends

DMRA RevenueDMRA Net incomeDMRA Net marginDMRA Gross profitDMRA Gross marginDMRA Operating incomeDMRA Operating marginDMRA Operating cash flowDMRA Free cash flowDMRA Return on equityDMRA Stock buybacksDMRA Dividends paidDMRA Total assetsDMRA Total liabilitiesDMRA Shareholders’ equityDMRA overview →